DE3680093D1 - Neue e.coli-wirtszelle und ihre verwendung. - Google Patents

Neue e.coli-wirtszelle und ihre verwendung.

Info

Publication number
DE3680093D1
DE3680093D1 DE8686118121T DE3680093T DE3680093D1 DE 3680093 D1 DE3680093 D1 DE 3680093D1 DE 8686118121 T DE8686118121 T DE 8686118121T DE 3680093 T DE3680093 T DE 3680093T DE 3680093 D1 DE3680093 D1 DE 3680093D1
Authority
DE
Germany
Prior art keywords
tosyl
inhibited
coli
new
host cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686118121T
Other languages
English (en)
Inventor
Keijiro Sugimura
Shunjiro Sugimoto
Hounai Shirasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE3680093D1 publication Critical patent/DE3680093D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE8686118121T 1985-12-27 1986-12-29 Neue e.coli-wirtszelle und ihre verwendung. Expired - Lifetime DE3680093D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60295140A JPH0650985B2 (ja) 1985-12-27 1985-12-27 新規な大腸菌宿主

Publications (1)

Publication Number Publication Date
DE3680093D1 true DE3680093D1 (de) 1991-08-08

Family

ID=17816794

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686118121T Expired - Lifetime DE3680093D1 (de) 1985-12-27 1986-12-29 Neue e.coli-wirtszelle und ihre verwendung.

Country Status (7)

Country Link
US (1) US4874697A (de)
EP (1) EP0230670B1 (de)
JP (1) JPH0650985B2 (de)
AT (1) ATE64954T1 (de)
DE (1) DE3680093D1 (de)
ES (1) ES2028785T3 (de)
GR (1) GR3002245T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333777C (en) * 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
IT1246296B (it) * 1990-07-25 1994-11-17 Sclavo Spa Procedimento di estrzione e purificazione del gamma interferone umano ricombinante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590159A (en) * 1981-08-21 1986-05-20 University Patents, Inc. Enhancement of expression of protein synthesis in E. coli
JPS59146597A (ja) * 1983-02-08 1984-08-22 Toray Ind Inc インタ−フエロン様ポリペロチドの生産方法
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields

Also Published As

Publication number Publication date
ES2028785T3 (es) 1992-07-16
ATE64954T1 (de) 1991-07-15
JPH0650985B2 (ja) 1994-07-06
GR3002245T3 (en) 1992-12-30
EP0230670B1 (de) 1991-07-03
JPS62155080A (ja) 1987-07-10
EP0230670A3 (en) 1988-11-23
US4874697A (en) 1989-10-17
EP0230670A2 (de) 1987-08-05

Similar Documents

Publication Publication Date Title
GB1412230A (en) Electrodeposition of enzymes
KR920012442A (ko) 피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법
NZ233451A (en) Production of vascular endothelial growth factor and dna encoding same
AU5078085A (en) Aspergillus niger transformation system
HK66293A (en) Human granulocyte colony stimulating factor
IE840095L (en) Methods for producing pure protein in vertebrate host cells
IL80022A0 (en) Recombinant fibroblast growth factors
HK1008049A1 (en) Transduced fibroblasts and use therefor
IE840493L (en) Biosynthetically produced human nerve growth factor.
UA41863C2 (uk) Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах
BE887529A (fr) Polypeptide preparer, par voie microbiologique avec sequence d'informations genetiques, microorganismes contenant ces informations genetiques et leur procedes de preparation
AU7177896A (en) Multidrug resistance gene
EP0835661A3 (de) Menslisches Interferon-Beta 2A zur Verwendung als Arzneimittel
DE3680093D1 (de) Neue e.coli-wirtszelle und ihre verwendung.
GB9118664D0 (en) Cell culture
AU2209988A (en) Method for increasing the expression of polypeptides in recombinant cell culture
ES479962A1 (es) Metodos para eliminar efectos de anodo en el funcionamiento de una cuba de reduccion electrolitica.
WO2000057864A3 (en) Cyclic glycerophosphates and analogs thereof
EP0154566A3 (en) Viral enhancer dna segments
ES8507000A1 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre
EP0315950A3 (de) Verfahren zur Züchtung von Zellen, welche rekombinantes Protein exprimieren
AU575501B2 (en) Electrolytic preparation of perfluoroalkanoic acids and perfluoroalkanols
AU2098288A (en) Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids
ES8706857A1 (es) Sistema de anodos para la deposicion anodica de dioxido de manganeso electrolitico
KR960001818B1 (en) Method for producing hirudin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP